Please assess the completion status of the following clinical trial:

Trial Title: Acute Effects of Gabapentin in Sleep Parameters and Hormonal Release During Sleep in Older Men

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 60 years old or more,~* healthy men~Exclusion Criteria:~* Basal Apnea-Hypopnea index (aHI)\>=15~* Restless Legs Syndrome Symptons~* BMI less than 18.5 kg/m2 or greater than 30 kg/m2~* Less than 30 min. of regular physical activity (at least walking inside home, etc.)~* Plasma albumin below 3.5 mg/dL~* Psychoactive drugs use~* Drugs with muscle anabolic potential~* Current treatment for obesity or weight gain~* Enteral or parenteral feeding~* Inability to walk without assistance,~* Loss of independence in any activity of daily living~* Nocturia above 2 episodes~* Smoking more than 2 cigarettes per day~* Alcoholism (more than 2 doses a day)~* Prior epilepsy diagnosis~* Clinically evident atherosclerotic disease~* Dementia~* Depression~* Rheumatic diseases~* Cancer~* Diabetes (poorly controlled, HbA1C \> 7,0, requirement of insulin)~* Thyroid dysfunction without treatment~* Advanced stages in COPD, HF, liver or renal failure

- Gender: MALE
- Minimum Age: 60 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): A single dose of placebo with exactly the same characteristics of the active drug at bedtime.
- Gabapentin (Type: EXPERIMENTAL): A single dose of Gabapentin 300mg at bedtime.

Based on this trial design, predict the completion outcome and termination type (if applicable).